Allogeneic dendritic cell vaccine (electrofused with autologous tumor-derived cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic dendritic cell vaccine (electrofused with autologous tumor-derived cells), covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma [Phase 1, Phase 2]